| Anna Rose Shope, MD | |
|
1355 N 205th St, Box 356460, Shoreline, WA 98133-3215 | |
| (206) 542-5656 | |
| Not Available |
| Full Name | Anna Rose Shope |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 1355 N 205th St, Shoreline, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063611374 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD60218139 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Association Of University Physicians | 0446162697 | 3009 |
News Archive
Research sponsored by Cancer Research UK has identified mutations common to all tumour cells. Immunotherapies specific for these mutations could deliver chemotherapeutic agents to all tumour cells and destroy them.
Ligand Pharmaceuticals Incorporated and Neurogen Corporation announced today they have amended their merger agreement to increase the merger consideration payable
A Purdue University study sheds light on how cell damage is reversed by the cancer drug decitabine and identifies a potential biomarker that could indicate a patient's stage of cancer and response to treatment.
Women risk any number of strains, sprains, and injuries while working in their gardens, but by using braces designed specifically for women's bodies such as the ones made by Wellgate for Women, women are able to help reduce their pain and support their joints while still enjoying all the peace and relaxation that a garden brings.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
› Verified 9 days ago
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Research sponsored by Cancer Research UK has identified mutations common to all tumour cells. Immunotherapies specific for these mutations could deliver chemotherapeutic agents to all tumour cells and destroy them.
Ligand Pharmaceuticals Incorporated and Neurogen Corporation announced today they have amended their merger agreement to increase the merger consideration payable
A Purdue University study sheds light on how cell damage is reversed by the cancer drug decitabine and identifies a potential biomarker that could indicate a patient's stage of cancer and response to treatment.
Women risk any number of strains, sprains, and injuries while working in their gardens, but by using braces designed specifically for women's bodies such as the ones made by Wellgate for Women, women are able to help reduce their pain and support their joints while still enjoying all the peace and relaxation that a garden brings.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anna Rose Shope, MD Po Box 50095, Seattle, WA 98145-5095 Ph: () - | Anna Rose Shope, MD 1355 N 205th St, Box 356460, Shoreline, WA 98133-3215 Ph: (206) 542-5656 |
News Archive
Research sponsored by Cancer Research UK has identified mutations common to all tumour cells. Immunotherapies specific for these mutations could deliver chemotherapeutic agents to all tumour cells and destroy them.
Ligand Pharmaceuticals Incorporated and Neurogen Corporation announced today they have amended their merger agreement to increase the merger consideration payable
A Purdue University study sheds light on how cell damage is reversed by the cancer drug decitabine and identifies a potential biomarker that could indicate a patient's stage of cancer and response to treatment.
Women risk any number of strains, sprains, and injuries while working in their gardens, but by using braces designed specifically for women's bodies such as the ones made by Wellgate for Women, women are able to help reduce their pain and support their joints while still enjoying all the peace and relaxation that a garden brings.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
› Verified 9 days ago
Dorcas A Mclennan, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1201 N 175th St, Shoreline, WA 98133 Phone: 206-401-3165 Fax: 206-401-3201 | |
Mai Tran, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1355 N 205th St, Shoreline, WA 98133 Phone: 206-520-5000 | |
Diana L Villanueva, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1355 N 205th St, Shoreline, WA 98133 Phone: 206-542-5656 |